D07.30
Carcinoma in situ of unspecified female genital organs
Clinical Classification Guidelines
Medical Intelligence & Overview
Carcinoma in situ (CIS) of the female genital organs is a condition where abnormal cells are found in the tissues of these organs but have not yet invaded nearby tissues or spread to other parts of the body. The term 'in situ' indicates that the abnormal cells are confined to the surface layer and have not become invasive cancer. This diagnosis is important because it often signifies an early stage of potential malignancy, which can be effectively managed if detected early. The specific ICD-10 code D07.30 pertains to cases where the precise female genital organ has not been specified, but the abnormal cell growth has been identified within the female reproductive system.
Causes & Symptoms
Clinical Causes: Persistent infection with high-risk types of human papillomavirus (HPV) Chronic inflammation of the reproductive organs Exposure to carcinogenic substances or environmental toxins Genetic predisposition to abnormal cell growth Immune system suppression, either due to medications or health conditions History of previous abnormal cell changes or lesions in the genital area
Key Symptoms: Often asymptomatic; many cases are detected during routine screenings Unusual vaginal bleeding, such as bleeding between periods or after intercourse Unexplained vaginal discharge that may be abnormal in color or smell Pelvic discomfort or pressure, though these are less common Visible abnormal changes, such as lesions or discolorations on the genital skin or mucous membranes Persistent itching or irritation in the genital area
Diagnostic & Treatment
Diagnosis Path: Colposcopy: a detailed examination of the vaginal and cervical tissues using a specialized magnifying instrument Biopsy: removal of a small tissue sample for laboratory analysis to confirm the presence of carcinoma in situ HPV testing: to identify high-risk HPV types associated with cell changes Imaging tests: such as ultrasound or MRI, to evaluate the extent of tissue involvement if invasive cancer is suspected
Treatment Protocols: Surgical excision: removing abnormal tissue through procedures like loop electrosurgical excision procedure (LEEP), cold knife cone biopsy, or laser surgery Cryotherapy: freezing abnormal cells to destroy them Topical treatments: such as imiquimod cream or other medications that stimulate the immune response Regular follow-up examinations and Pap smears to monitor for recurrence or progression In some cases, additional procedures may be necessary if lesions are extensive or difficult to remove
Clinical Advice & FAQs
Billing Guidance
Is D07.30 a billable ICD-10 code?
Yes, D07.30 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D07.30?
Clinical documentation must specify the nature of Carcinoma in situ of unspecified female genital organs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference